Role of PET/CT in improving the cost effectiveness of nimotuzumab in nasopharyngeal carcinoma
For patients with LA-NPC with SUV<sub>max</sub> > 12.92, the addition of NTZ to CCRT can improve OS and is cost effective.
Authors
- Xiaobin Fu (ORCID: https://orcid.org/0000-0002-5005-8134)
- Zhao-dong Fei
- Chuanben Chen (ORCID: https://orcid.org/0000-0002-5994-8897)
- Tingting Li (ORCID: https://orcid.org/0000-0003-4583-946X)
Institutions
- Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Acta Otorhinolaryngologica Italica
- Published
- 2024-10-01
- DOI
- https://doi.org/10.14639/0392-100x-n2827
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.58
Funders
- Natural Science Foundation of Fujian Province